![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases expression | ISO | RGD:1606180 | 6480464 | o, p'-DDT results in decreased expression of RMI2 mRNA | CTD | PMID:19371625 | 1,2-dichloroethane | decreases expression | ISO | RGD:1621348 | 6480464 | ethylene dichloride results in decreased expression of RMI2 mRNA | CTD | PMID:28960355 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of RMI2 mRNA | CTD | PMID:30723492 | 17beta-estradiol | increases expression | ISO | RGD:1606180 | 6480464 | Estradiol results in increased expression of RMI2 mRNA | CTD | PMID:19167446 | 17beta-estradiol | decreases expression | ISO | RGD:1606180 | 6480464 | Estradiol results in decreased expression of RMI2 mRNA | CTD | PMID:23019147 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1606180 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RMI2 mRNA | CTD | PMID:21802500 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RMI2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1621348 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RMI2 mRNA | CTD | PMID:26377647 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | RGD:1606180 | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of RMI2 gene | CTD | PMID:31601247 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1621348 | 6480464 | Fenretinide results in decreased expression of RMI2 mRNA | CTD | PMID:28973697 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of RMI2 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | RGD:1606180 | 6480464 | Acrylamide results in decreased expression of RMI2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | RGD:1606180 | 6480464 | Aflatoxin B1 affects the expression of RMI2 protein | CTD | PMID:20106945 | aflatoxin B1 | increases methylation | ISO | RGD:1606180 | 6480464 | Aflatoxin B1 results in increased methylation of RMI2 gene | CTD | PMID:27153756 | aflatoxin B1 | increases expression | ISO | RGD:1606180 | 6480464 | Aflatoxin B1 results in increased expression of RMI2 mRNA | CTD | PMID:21632981, PMID:22100608 | all-trans-retinoic acid | decreases expression | ISO | RGD:1606180 | 6480464 | Tretinoin results in decreased expression of RMI2 mRNA | CTD | PMID:33167477 | arsenous acid | multiple interactions | ISO | RGD:1606180 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RMI2 protein] | CTD | PMID:26598702 | azathioprine | decreases expression | ISO | RGD:1606180 | 6480464 | Azathioprine results in decreased expression of RMI2 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | decreases expression | ISO | RGD:1606180 | 6480464 | Benzo(a)pyrene results in decreased expression of RMI2 mRNA | CTD | PMID:21802500 | benzo[a]pyrene | increases expression | ISO | RGD:1606180 | 6480464 | Benzo(a)pyrene results in increased expression of RMI2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | RGD:1606180 | 6480464 | Benzo(a)pyrene affects the methylation of RMI2 promoter | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | RGD:1606180 | 6480464 | bisphenol A results in decreased expression of RMI2 mRNA | CTD | PMID:19371625 | bisphenol A | decreases methylation | ISO | RGD:1606180 | 6480464 | bisphenol A results in decreased methylation of RMI2 gene | CTD | PMID:31601247 | bisphenol A | affects expression | ISO | RGD:1606180 | 6480464 | bisphenol A affects the expression of RMI2 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RMI2 mRNA | CTD | PMID:25181051 | calcitriol | decreases expression | ISO | RGD:1606180 | 6480464 | Calcitriol results in decreased expression of RMI2 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | RGD:1606180 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RMI2 mRNA | CTD | PMID:21592394 | cisplatin | increases expression | ISO | RGD:1606180 | 6480464 | Cisplatin results in increased expression of RMI2 mRNA | CTD | PMID:27594783 | copper atom | multiple interactions | ISO | RGD:1606180 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RMI2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1606180 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RMI2 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | RGD:1606180 | 6480464 | Copper Sulfate results in decreased expression of RMI2 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | RGD:1606180 | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | RGD:1606180 | 6480464 | Coumestrol results in increased expression of RMI2 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RGD:1606180 | 6480464 | Cyclosporine results in decreased expression of RMI2 mRNA | CTD | PMID:20106945 more ... | cyclosporin A | decreases methylation | ISO | RGD:1606180 | 6480464 | Cyclosporine results in decreased methylation of RMI2 promoter | CTD | PMID:27989131 | diarsenic trioxide | multiple interactions | ISO | RGD:1606180 | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RMI2 protein] | CTD | PMID:26598702 | dioxygen | decreases expression | ISO | RGD:1606180 | 6480464 | Oxygen deficiency results in decreased expression of RMI2 mRNA | CTD | PMID:26516004 | dorsomorphin | multiple interactions | ISO | RGD:1606180 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RMI2 mRNA | CTD | PMID:27188386 | Enterolactone | increases expression | ISO | RGD:1606180 | 6480464 | 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA | CTD | PMID:19167446 | Enterolactone | multiple interactions | ISO | RGD:1606180 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA | CTD | PMID:19167446 | ethyl methanesulfonate | increases expression | ISO | RGD:1606180 | 6480464 | Ethyl Methanesulfonate results in increased expression of RMI2 mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | ISO | RGD:1606180 | 6480464 | Formaldehyde results in increased expression of RMI2 mRNA | CTD | PMID:23649840 | genistein | decreases expression | ISO | RGD:1606180 | 6480464 | Genistein results in decreased expression of RMI2 mRNA | CTD | PMID:19371625 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of RMI2 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | RGD:1606180 | 6480464 | Hydrogen Peroxide affects the expression of RMI2 mRNA | CTD | PMID:20044591 | leflunomide | decreases expression | ISO | RGD:1606180 | 6480464 | leflunomide results in decreased expression of RMI2 mRNA | CTD | PMID:28988120 | menadione | affects expression | ISO | RGD:1606180 | 6480464 | Vitamin K 3 affects the expression of RMI2 mRNA | CTD | PMID:20044591 | N-methyl-4-phenylpyridinium | decreases expression | ISO | RGD:1606180 | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of RMI2 mRNA | CTD | PMID:24810058 | ozone | multiple interactions | ISO | RGD:1621348 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RMI2 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RMI2 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of RMI2 mRNA | CTD | PMID:32680482 | phenylmercury acetate | decreases expression | ISO | RGD:1606180 | 6480464 | Phenylmercuric Acetate results in decreased expression of RMI2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1606180 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RMI2 mRNA | CTD | PMID:27188386 | potassium dichromate | increases expression | ISO | RGD:1606180 | 6480464 | Potassium Dichromate results in increased expression of RMI2 protein | CTD | PMID:23718831 | propanal | decreases expression | ISO | RGD:1606180 | 6480464 | propionaldehyde results in decreased expression of RMI2 mRNA | CTD | PMID:26079696 | resveratrol | decreases expression | ISO | RGD:1606180 | 6480464 | resveratrol results in decreased expression of RMI2 mRNA | CTD | PMID:19371625 | resveratrol | multiple interactions | ISO | RGD:1606180 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of RMI2 mRNA | CTD | PMID:19167446 | SB 431542 | multiple interactions | ISO | RGD:1606180 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RMI2 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | RGD:1606180 | 6480464 | sodium arsenite results in increased expression of RMI2 mRNA | CTD | PMID:34032870 | sunitinib | decreases expression | ISO | RGD:1606180 | 6480464 | Sunitinib results in decreased expression of RMI2 mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | RGD:1606180 | 6480464 | Temozolomide results in decreased expression of RMI2 mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | ISO | RGD:1606180 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RMI2 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | RGD:1606180 | 6480464 | Testosterone results in decreased expression of RMI2 mRNA | CTD | PMID:21592394 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of RMI2 mRNA | CTD | PMID:33387578 | thapsigargin | decreases expression | ISO | RGD:1606180 | 6480464 | Thapsigargin results in decreased expression of RMI2 mRNA | CTD | PMID:22378314 | trovafloxacin | decreases expression | ISO | RGD:1621348 | 6480464 | trovafloxacin results in decreased expression of RMI2 mRNA | CTD | PMID:35537566 | tunicamycin | decreases expression | ISO | RGD:1606180 | 6480464 | Tunicamycin results in decreased expression of RMI2 mRNA | CTD | PMID:22378314 | tunicamycin | increases expression | ISO | RGD:1606180 | 6480464 | Tunicamycin results in increased expression of RMI2 mRNA | CTD | PMID:29453283 | urethane | decreases expression | ISO | RGD:1606180 | 6480464 | Urethane results in decreased expression of RMI2 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1606180 | 6480464 | Valproic Acid results in increased expression of RMI2 mRNA | CTD | PMID:29154799 | zearalenone | decreases expression | ISO | RGD:1606180 | 6480464 | Zearalenone results in decreased expression of RMI2 mRNA | CTD | PMID:19371625 | |